Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The keratinocyte proliferation pathway refers to the network of molecular signals and cellular processes that regulate the growth and division of keratinocytes, the predominant cell type in the epidermis. This pathway is essential for skin homeostasis, wound healing, and barrier function. Key components include growth factors (EGF, TGF-α, FGFs, oncostatin M, IL-17A), MAPK/ERK and PI3K/Akt signaling, and transcription factors (p63, STAT3). Dysregulation can lead to hyperproliferative disorders like psoriasis and skin cancers.
Varies depending on the specific molecule targeted within the pathway. Examples include inhibition of MAPK/ERK, PI3K/Akt/mTOR, or modulation of transcription factor activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratinocyte Proliferation Pathway.